Product NDC: | 63304-191 |
Proprietary Name: | Desvenlafaxine |
Non Proprietary Name: | Desvenlafaxine |
Active Ingredient(s): | 50 mg/1 & nbsp; Desvenlafaxine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, EXTENDED RELEASE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63304-191 |
Labeler Name: | Ranbaxy Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA204150 |
Marketing Category: | NDA |
Start Marketing Date: | 20130305 |
Package NDC: | 63304-191-30 |
Package Description: | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-30) |
NDC Code | 63304-191-30 |
Proprietary Name | Desvenlafaxine |
Package Description | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (63304-191-30) |
Product NDC | 63304-191 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Desvenlafaxine |
Dosage Form Name | TABLET, EXTENDED RELEASE |
Route Name | ORAL |
Start Marketing Date | 20130305 |
Marketing Category Name | NDA |
Labeler Name | Ranbaxy Pharmaceuticals Inc. |
Substance Name | DESVENLAFAXINE |
Strength Number | 50 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Norepinephrine Uptake Inhibitors [MoA],Serotonin and Norepinephrine Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |